Study adds clinical evidence for lipid emulsion in pet neurotoxicosis: full analysis

A new multicenter case series is giving veterinary teams a clearer look at what intravenous lipid emulsion therapy may actually be doing in dogs and cats with suspected neurotoxicosis. In 34 companion animal cases treated across eight veterinary hospitals, researchers found that xenobiotics frequently shifted into the plasma lipid fraction during ILE infusion, and animals with higher lipid-to-aqueous ratios were more likely to show short-term neurologic improvement. The study, posted as a preprint on February 25, 2026, addresses a longstanding gap in veterinary toxicology: ILE has been used for years, but direct in vivo evidence of this “lipid sink” or “lipid shuttle” effect in clinical patients has been limited. (research-portal.uu.nl)

That gap matters because ILE has become familiar in emergency and critical care settings largely on the strength of case reports, toxicology experience, and extrapolation from experimental and human literature. A 2011 review noted that veterinary evidence was sparse and called for more research, even as poison control centers and clinicians were already using ILE for certain lipophilic toxicoses. More recent retrospective work, including a 2023 Frontiers study covering 313 dogs and 100 cats, shows how widely the therapy has been adopted in practice, but retrospective datasets still leave open the question of why some patients seem to improve quickly and others do not. (pubmed.ncbi.nlm.nih.gov)

In the new series, dogs and cats with acute neurologic signs and suspected toxic exposure were enrolled between June 2020 and November 2021. Blood was collected immediately before ILE, at the end of infusion, and again four hours later. The final analysis included 34 animals, 27 dogs and seven cats, with 17 different xenobiotics identified. By the end of the infusion, lipid-fraction xenobiotic concentrations exceeded aqueous concentrations in 28 of 34 cases. Early improvement, defined as neurologic change from ILE initiation to 4 to 6 hours later, occurred in 14 of 34 animals and was associated with a higher geometric mean lipid-to-aqueous ratio of 5.7. Notably, log P, a standard measure of lipophilicity often used to judge whether ILE might work, did not correlate with partitioning or outcome in this cohort. (research-portal.uu.nl)

That last point may be one of the most practice-relevant findings. In real-world toxicology cases, clinicians often have incomplete exposure histories and may rely on a toxicant’s presumed lipophilicity when deciding whether to try ILE. This study suggests that approach may be too simplistic. If confirmed in peer-reviewed publication, the data would support a more nuanced view: some compounds may partition into lipid in vivo in ways that are not well captured by log P alone, and clinical response may depend on timing, dose, co-treatments, redistribution, or patient-specific factors. That’s an inference from the study rather than a direct conclusion, but it fits the reported results. (research-portal.uu.nl)

The broader literature still argues for caution. Prior veterinary publications describe ILE as generally well tolerated, but adverse events have been reported, including phlebitis, hemolysis, pancreatitis, fat overload, and pulmonary complications such as acute lung injury or suspected ARDS. A Frontiers case report highlighted one dog with suspected ARDS after ILE, underscoring that even if complications are uncommon, they’re clinically important in unstable patients. Meanwhile, retrospective reports continue to suggest that many poisoned animals recover quickly after ILE, especially in neurotoxic presentations, but those studies cannot fully separate the effect of ILE from concurrent supportive care and the natural course of intoxication. (frontiersin.org)

Why it matters: For veterinarians, this case series strengthens the biologic plausibility behind an already familiar rescue therapy without settling the efficacy question. It gives clinicians better language for discussing ILE with pet parents and referral partners: there is now prospective clinical evidence that plasma partitioning occurs in many cases, and that stronger partitioning tracks with early neurologic improvement, but benefit was not universal. Only 14 of 34 animals improved in the short term, and the study does not establish causation or define which toxicants are best candidates. In practice, that means ILE remains a potentially valuable adjunct in selected neurotoxic emergencies, especially when conventional decontamination and supportive care may not be enough, but it should still be used thoughtfully and with monitoring. (research-portal.uu.nl)

What to watch: The next milestones are peer review, fuller reporting on adverse events and toxicant-specific outcomes, and larger prospective studies that compare ILE-treated patients with matched controls or standardized protocols. If those data emerge, they could help move ILE from a case-by-case rescue decision toward more evidence-based guidance on when to use it, when to avoid it, and how to counsel pet parents about expected neurologic recovery in the first few hours after treatment. (research-portal.uu.nl)